// App-Quantinova.ai

: CAR-T Therapy Followed By Unrelated Cord Blood Transplantation for the Treatment of Children and Young Adults Relapsed/Refractory B-Cell ALL: Superior Survival but Relatively High Post-Transplant Relapse

Researchers

Presenter

  • Guangyu Sun

Principal Investigators

  • Baolin Tang

  • Xiang Wan

  • Wen Yao

  • Kaidi Song

  • Liangquan Geng

  • Ping Qiang

  • Yue Wu

  • Lijun Zhu

  • Dongyao Wang

  • Yun Wu

  • Huilan Liu

  • Zimin Sun

  • Xiaoyu Zhu

Medical Centers

  • Department of Hematology, University Of Science and Technology Of China, Hefei City, China

  • The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China

  • Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, U, Hefei, China

  • The First Affiliated Hospital of University of Science and Technology of China, Hefei, China

  • The First Affiliated Hospital of USTC, Hefei, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • B-cell acute lymphoblastic leukemia

Biomarkers

  • N/A

Drug/Treatment

  • Allopurinol

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved